Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ABBOTT's POLITICAL ACTION COMMITTEE HAS CONTRIBUTED $ 117,552

Executive Summary

ABBOTT's POLITICAL ACTION COMMITTEE HAS CONTRIBUTED $ 117,552 to federal campaigns and other political committees so far in 1988, according to submissions by the company to the Federal Election Commission. The reports detail contributions up to Oct. 19. The top recipient of contributions from the Abbott Laboratories Better Government Fund during the year is George Voinovich, the Republican mayor of Cleveland, Ohio, who is challenging Sen. Howard Metzenbaum (D-Ohio) for the seat the senator has held since 1974. Voinovich has received $9,000 from Abbott during the year: $4,000 for the primary and $ 5,000 for the general election, including $ 3,500 since Sept. 1. Metzenbaum is a member of the Labor and Human Resources Committee and chairs the committee's Labor Subcommittee. He also is chairman of the Judiciary Committee's Antitrust, Monopolies and Business Rights Subcommittee. In the health care area, Metzenbaum most recently was an advocate for increased appropriations to FDA's orphan drug program. Recipients of Abbott funds in the "pre-election" period from Oct. 1 to Oct. 19 include Slade Gorton (R-Wash.), who is looking to return to the Senate after being defeated by Brock Adams in 1986. Gorton's campaign for the seat held by retiring Senator Daniel Evans received $ 2,000 from Abbott. Abbott also added $ 500 in October to the $ 2,000 it had previously donated to Rep. James Jeffords' (R-Vt.) campaign for the seat being vacated by Robert Staffords. State Senator Susan Engeleiter (R-Wis.) received an additional $ 1,000 in October, bringing Abbott's contributions this year to her campaign for the seat of the retiring Sen. William Proxmire (D) to $ 3,000. As of Sept. 30, Baxter's PAC had distributed $ 29,000 to federal candidates and other political committees. Receiving $ 1,000 contributions from Baxter in the third quarter of 1988 for general election Senate campaigns were Sen. David Durenberger (R-Minn.), ranking minority member of the Finance Committee's health subcommittee, and health subcommittee members Sen. John Chaffee (D-RI) and Sen. Donald Reigle (D-Mich.). Baxter also contributed $ 1,000 to Sen. Orrin Hatch (R-Utah), the ranking minority member on the Labor and Human Resources Committee. Vice presidential nominee Sen. Lloyd Bentsen (D-Tex.), chairman of the Finance Committee, received $ 1,000 for his Senate race, as did Sens. Pete Wilson (R-Calif.) and William Roth (R-Del.). Lilly's PAC contributed $ 103,860 to federal candidates and other political committees through Oct. 19. Of those funds, $ 46,300 were disbursed in August, Voinovich, Durenberger, Trent Lott (R-Miss.) and Peter Dawkins (R-NJ) all received $ 5,000 donations from Lilly in August. Pfizer's PAC distributed $ 128,212 to federal campaigns through Oct. 19. Among those singled out by Pfizer for assistance in the October pre-election period were House Energy and commerce Committee Chairman John Dingell (D-Mich.), who received $ 1,000.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014540

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel